Rhythm Pharmaceuticals, Inc. (RYTM)
NASDAQ·Healthcare·Biotechnology
$106.47
-1.45%
Mkt Cap $7.28B
Analyst Ratings
Buy
22
Hold
0
Sell
0
Price Target (39 analysts)
$139.00
Range $125.00 – $155.00
Implied Upside
+30.6%
Consensus $139.00 vs current $106.47